Yahoo Web Search

  1. Amgen Wins Enbrel U.S. Patent Litigation Against Novartis

    Zacks via Yahoo FinanceAug 12 13:44 PM

    Amgen Inc. AMGN announced that a district court of New Jersey has upheld the validity of its two patents on blockbuster rheumatoid arthritis drug Enbrel against Novartis’ NVS generic ...

  2. Celldex Therapeutics Inc (CLDX) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 08 20:23 PM

    Most recently, Diane served as Chief Medical Officer of GTx, Inc., a public biopharmaceutical company focused on the development drugs that target nuclear hormone receptors. Previously ...

  3. Shares of Amgen Inc. AMGN have risen 22.6% in the past three months against a 0.9% decrease registered by the industry during this period. The district court’s decision...upholding the ...

  4. Tilray (TLRY) to Report Q2 Earnings: What's in the Cards?

    Zacks via Yahoo FinanceAug 09 14:42 PM

    Tilray, Inc. TLRY is scheduled to release second-quarter 2019 results on Aug 13. Tilray produces medical cannabis in Canada and Europe. Medical cannabis is now authorized at the national ...

  5. Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss

    Zacks via Yahoo FinanceAug 05 14:59 PM

    Shares of Momenta Pharmaceuticals Inc. MNTA gained 1.8% on Aug 2 even though the company reported a wider-than-expected loss and missed revenue estimates in the second quarter. The company ...

  6. This conference call may contain forward-looking statements, including statements relating to Amphastar Pharmaceuticals. These statements are not historical facts but rather based on Amphastar ...

  7. The marijuana industry is projected to grow at an annual rate of about 17% until it reaches $55.8 billion a year in 2025. The cannabis market has roughly tracked the S&P 500’s expansion in 2019 ...

  8. It was a busy week for the biotech sector after the second-quarter earnings with collaborations and pipeline updates taking center stage. While Amgen AMGN secured a key win against Novartis ...

  9. Stocks recently featured in the blog include: Canopy Growth Corporation CGC and Tilray Inc. TLRY. The cannabis market has roughly tracked the S&P 500’s expansion in 2019. A popular ETF ...

  10. My colleagues and I are excited to continue our mission to forever change the migraine treatment landscape, with the potential launch of our first product in a little over six months. Assuming ...

  1. Ads
    related to Sandoz, Inc